Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa
Author(s) -
Joanna C. Evans,
Michael C. Stead,
Mark P. Nicol,
Heidi Segal
Publication year - 2008
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkn433
Subject(s) - inha , isoniazid , genotype , biology , mycobacterium tuberculosis , virology , drug resistance , tuberculosis , rifampicin , microbiology and biotechnology , genetics , medicine , antibiotics , gene , pathology
Molecular assays to detect drug resistance in Mycobacterium tuberculosis are more rapid than standard drug susceptibility testing. To evaluate the efficacy of such assays in this setting, the GenoType MTBDRplus assay (HAIN Lifescience) and multiplex allele-specific PCR assays were carried out.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom